OAT-2068

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameOAT-2068

Drug Alias NameCHIT1 inhibitor (OncoArendi Therapeutics)chitotriosidase-1 inhibitor (OncoArendi Therapeutics)CHIT1 inhibitor (OncoArendi Therapeutics)CHIT1 inhibitor (Molecure SA)OAT-2068

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionChitinase 1 inhibitors

TargetsChitinase 1

Therapy Area/IndicationsSarcoidosisIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMolecure SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecure SA

Active IndicationsN/A

Inactive IndicationsSarcoidosisIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[4]

Other Information

ATC CodeN/A